Who Just RaisedPullman, WA · Health Care · Form D filed Sep 15, 2026
Hexamer Therapeutics, Inc raised $500K
Hexamer Therapeutics, Inc is a biotechnology company based in Pullman, Washington. In a Form D filed with the SEC on September 15, 2026, it reported raising $500,000 from 2 investors as part of an offering of up to $2,500,000. The first sale in the offering took place on July 7, 2026.
- 3rd Form D since 2019. Earlier new notices: Jun 27, 2024 · Dec 27, 2019. All filings on EDGAR
- Still raising. $2M of the $2.5M offering was still unsold at filing.
$1.2M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Jun 27, 2024. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 15, 2026 | $500K | $2.5M | 2 |
| Jun 27, 2024 | $651K | $6.6M | 9 |
Lead score
20 out of 100
early raise still raising
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $500,000
- Offering size
- $2,500,000
- Investors so far
- 2
- First sale
- July 7, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Pullman, Washington
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $500,000 | $2,500,000 | 2 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 14, 2026 · Health Care funding in Washington · September 2026 funding report
Similar raises
Q-Immune, Inc.
Seattle, WA · filed Sep 28
CAR-T can cure. Q-Immune makes it safe, with a lab that teaches AI how engineered cells behave.
First Form DStill raising
Seattle Neurosound Solutions, Inc.
Seattle, WA · filed Sep 22First Form DStill raising
DexCare, Inc.
Seattle, WA · filed Sep 143rd Form D since 2021Still raising
Aptevo Therapeutics Inc.
Seattle, WA · filed Aug 26
2nd Form D since 2025
MalarVx, Inc.
Seattle, WA · filed Aug 254th Form D since 2012Still raising
Strella Biotechnology, Inc.
Seattle, WA · filed Aug 143rd Form D since 2020Still raising
Automera US Inc.
Seattle, WA · filed Aug 72nd Form D since 2023Still raising
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising